Global Veterinary Vaccines Market Size - Forecasts to 2027

Global Veterinary Vaccines Market Size - Forecasts to 2027

According to a new market research report published by Global Market Estimates, the Global Veterinary Vaccines Market is projected to grow at a CAGR value of 12.8% from 2022 to 2027. The increased frequency of zoonotic illnesses, activities by governmental bodies and animal associations to protect animal care, and the growing preference for animal-derived packaged foods are driving the expansion of this market.

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Veterinary Vaccines Market - Forecast to 2027" https://www.globalmarketestimates.com/market-report/veterinary-vaccines-market-3726

 Key Market Insights

·         The porcine vaccines segment is expected to be the fastest growing segment in the veterinary vaccines market from 2022 to 2027 as per the component outlook

·         The is livestock segment expected to be the fastest growing segment in the veterinary vaccines market from 2022 to 2027 as per the disease outlook

·         The inactivated vaccines segment is expected to be the largest segment in the veterinary vaccines market from 2022 to 2027 as per the technology outlook

·         North America (the United States, Canada, and Mexico) will have a dominant share in the global veterinary vaccines market from 2022 to 2027

·         Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Ceva, Virbac, Vetoquinol, Phibro Animal Health, Hester Biosciences, HIPRA, Biogenesis Bago, Tianjin Ringpu, China Animal Husbandry, Jinyu Biotechnology, among others are the key players in the global veterinary vaccines market.

Type Outlook (Revenue, USD Billion, 2022 - 2027)

·         Porcine Vaccines

·         Poultry Vaccine

·         Livestock Vaccine

·         Companion Animal Vaccine

·         Aquaculture Vaccines

·         Other Animal Vaccines

By Diseases Outlook (Revenue, USD Billion, 2022 - 2027)

·         Porcine

·         Poultry

·         Livestock

·         Companion Animal

·         Aquaculture

·         Others

Technology Outlook (Revenue, USD Billion, 2022 - 2027)

·         Live Attenuated Vaccines

·         Inactivated Vaccines

·         Toxoid Vaccines

·         Recombinant Vaccines

·         Other Vaccines

Regional Outlook (Revenue, USD Billion, 2022-2027)

North America                                                                                 

  • The U.S.
  • Canada
  • Mexico

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of APAC

Central & South America

  • Brazil
  • Argentina
  • Rest of CSA

Middle East & Africa

  • Saudi Arabia
  • UAE
  • Rest of MEA

 

Contact: Yash Jain

Email address: yash.jain@globalmarketestimates.com

Phone Number: +16026667238